Cytek Biosciences (CTKB) Change in Account Payables (2020 - 2026)
Cytek Biosciences posted quarterly Change in Account Payables of $390000.0 for Q1 2026, down 4.88% year-on-year from $410000.0 in Q1 2025, and up 129.79% on a QoQ basis from -$1.3 million in Q4 2025.
Cytek Biosciences (CTKB) has 7 years of Change in Account Payables data on file, last reported at $390000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 4.88% year-over-year to $390000.0; the trailing twelve-month figure through Mar 2026 stood at $428000.0 (down 81.99% YoY), and the FY2025 full-year result was $448000.0, down 82.65% from the prior year.
- Change in Account Payables for Q1 2026 stood at $390000.0, up from -$1.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.8 million in Q1 2022 and bottomed at -$2.0 million in Q2 2023.
- The 5-year median for Change in Account Payables is $390000.0 (2026), against an average of $205764.7.
- The widest annual swing landed in 2022, when Change in Account Payables surged 2383.93%; it then slumped 607.36% in 2025.
- A 5-year view of Change in Account Payables shows it stood at -$908000.0 in 2022, then sank by 97.58% to -$1.8 million in 2023, then jumped by 114.38% to $258000.0 in 2024, then plunged by 607.36% to -$1.3 million in 2025, then soared by 129.79% to $390000.0 in 2026.
- The last three Change in Account Payables figures came in at $390000.0 (Q1 2026), -$1.3 million (Q4 2025), and $588000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 390,000.00 |
| Mar 31, 2026 | 390,000.00 |
| Dec 31, 2025 | -1.31 Mn |
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | 588,000.00 |
| Sep 30, 2025 | 588,000.00 |
| Jun 30, 2025 | 759,000.00 |
| Jun 30, 2025 | 759,000.00 |
| Mar 31, 2025 | 410,000.00 |
| Mar 31, 2025 | 410,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | 2.23 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | -519,000.00 |
| Jun 30, 2024 | -519,000.00 |
| Mar 31, 2024 | 615,000.00 |
| Mar 31, 2024 | 615,000.00 |
| Dec 31, 2023 | -1.79 Mn |
| Dec 31, 2023 | -1.79 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Mar 31, 2023 | 305,000.00 |
| Mar 31, 2023 | 305,000.00 |
| Dec 31, 2022 | -908,000.00 |
| Dec 31, 2022 | -908,000.00 |
| Sep 30, 2022 | -907,000.00 |
| Sep 30, 2022 | -907,000.00 |
| Jun 30, 2022 | 895,000.00 |
| Jun 30, 2022 | 895,000.00 |
| Mar 31, 2022 | 2.78 Mn |
| Mar 31, 2022 | 2.78 Mn |
| Dec 31, 2021 | -742,000.00 |
| Dec 31, 2021 | -742,000.00 |
| Sep 30, 2021 | 635,000.00 |
| Sep 30, 2021 | 635,000.00 |
| Jun 30, 2021 | -261,000.00 |
| Jun 30, 2021 | -261,000.00 |
| Mar 31, 2021 | 112,000.00 |
| Mar 31, 2021 | 112,000.00 |
| Dec 31, 2020 | 1.72 Mn |
| Dec 31, 2020 | 1.72 Mn |
| Sep 30, 2020 | -1.61 Mn |
| Sep 30, 2020 | -1.61 Mn |